MORONI, MAURO
 Distribuzione geografica
Continente #
EU - Europa 11.851
AS - Asia 8.845
NA - Nord America 8.328
SA - Sud America 754
AF - Africa 188
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 9
Totale 30.018
Nazione #
US - Stati Uniti d'America 7.888
GB - Regno Unito 4.537
CN - Cina 3.228
SG - Singapore 2.343
IT - Italia 1.842
DE - Germania 1.549
SE - Svezia 963
RU - Federazione Russa 916
HK - Hong Kong 682
VN - Vietnam 644
BR - Brasile 555
TR - Turchia 492
FR - Francia 414
UA - Ucraina 401
IN - India 375
CA - Canada 362
KR - Corea 358
NL - Olanda 309
IE - Irlanda 300
BD - Bangladesh 280
FI - Finlandia 211
EU - Europa 166
PL - Polonia 106
JP - Giappone 75
CI - Costa d'Avorio 72
CO - Colombia 69
ID - Indonesia 58
AR - Argentina 57
BE - Belgio 54
GR - Grecia 51
AU - Australia 39
IQ - Iraq 37
TW - Taiwan 37
CH - Svizzera 35
MX - Messico 34
PH - Filippine 34
AL - Albania 30
ZA - Sudafrica 29
PK - Pakistan 26
UZ - Uzbekistan 25
EC - Ecuador 24
AT - Austria 21
EG - Egitto 18
MY - Malesia 18
RO - Romania 18
ES - Italia 17
IR - Iran 17
MA - Marocco 14
TH - Thailandia 14
CL - Cile 13
DK - Danimarca 12
LB - Libano 12
NP - Nepal 12
SA - Arabia Saudita 12
TN - Tunisia 11
CZ - Repubblica Ceca 10
NO - Norvegia 10
PY - Paraguay 10
VE - Venezuela 10
BG - Bulgaria 9
IL - Israele 9
JM - Giamaica 9
KE - Kenya 9
MM - Myanmar 9
AE - Emirati Arabi Uniti 8
OM - Oman 8
PT - Portogallo 8
CR - Costa Rica 7
DZ - Algeria 7
ET - Etiopia 7
PA - Panama 7
PE - Perù 7
UY - Uruguay 7
AZ - Azerbaigian 6
JO - Giordania 6
LT - Lituania 6
AO - Angola 5
KZ - Kazakistan 5
RS - Serbia 5
GT - Guatemala 4
HU - Ungheria 4
KG - Kirghizistan 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
HN - Honduras 3
MU - Mauritius 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GA - Gabon 2
KW - Kuwait 2
MD - Moldavia 2
NG - Nigeria 2
PR - Porto Rico 2
SN - Senegal 2
TT - Trinidad e Tobago 2
Totale 30.156
Città #
Southend 4.169
Singapore 1.278
Ashburn 664
Chandler 647
Hong Kong 623
San Jose 529
Beijing 514
Seattle 457
Hangzhou 444
Milan 434
Princeton 381
Frankfurt am Main 344
Dublin 299
Wilmington 293
Jacksonville 274
Ann Arbor 265
Council Bluffs 264
Redmond 252
Dallas 232
Los Angeles 222
Toronto 216
Hanover 208
Santa Clara 179
Ho Chi Minh City 178
Nanjing 175
Woodbridge 162
Lauterbourg 159
Guangzhou 152
Bengaluru 151
New York 150
Mountain View 148
Dearborn 143
Des Moines 141
Buffalo 138
Sakarya 136
Hanoi 125
Boardman 113
Moscow 112
Rome 112
Serra 111
Houston 101
Shanghai 96
Somerville 96
Hefei 94
Ottawa 92
Grafing 89
Warsaw 88
Jinan 86
Istanbul 85
Andover 81
The Dalles 77
Fairfield 75
Abidjan 71
Columbus 69
Tianjin 66
Phoenix 64
Bogotá 60
Dong Ket 60
Tokyo 59
Cangzhou 57
Shenyang 57
Berlin 54
Redwood City 54
Changsha 51
Munich 50
Brussels 49
Hebei 49
Seoul 49
Zhengzhou 47
São Paulo 45
Athens 43
Kiez 43
Helsinki 38
Nanchang 37
Shenzhen 37
Mumbai 33
Fuzhou 32
Jiaxing 32
Bitonto 28
Da Nang 28
Nürnberg 28
Pisa 28
London 27
Nuremberg 27
Belo Horizonte 25
Central District 25
Eitensheim 25
Fremont 24
Haiphong 24
Kunming 24
San Diego 24
Tirana 24
Wuhan 23
Ningbo 22
Auburn Hills 21
Cambridge 21
Chengdu 21
Falls Church 21
Padova 21
Florence 20
Totale 18.491
Nome #
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes 914
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies 568
Manuale di malattie infettive 559
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial 390
Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy 379
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis 356
Malattie infettive 351
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection 350
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region : outcome after treatment in recently infected individuals 345
GABergic neurons in the diencephalon and anterior cingulate cortex of the human brain during ageing 335
Prevalence of HIV-1 resistant strains in recent seroconverters 311
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1 297
In vitro efficacy of a non-conventional (folding) HIV-1 protease inhibitor without selection of resistance 296
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy 287
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 282
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals 276
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection 272
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection 272
High prevalence of human T-lymphotropic virus type 1 (HTLV-1) in immigrant male-to-female transsexual sex workers with HIV-1 infection 271
Clinical diagnosis of mycobacterial diseases versus autopsy findings in 350 patients with AIDS 265
Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001 263
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 263
Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab 263
[13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity 260
Introduzione allo studio delle malattie infettive 259
Susceptibility to a non-conventional (folding) protease inhibitor of human immunodeficiency virus type 1 isolates in vitro 257
Efficacia di Caspofungin nella candidosi esofagea HIV-correlata multifarmacoresistente 257
Comparison between Spoligotyping and IS6110 Restriction Fragment Polymorphism in Molecular Genotyping Analysis of Mycobacterium tuberculosis strains 253
Consensus document on controversial issues for the treatment of hospital-associated pneumonia 251
Epidemiological spread of drug-resistant HIV-1 strains 251
Pregnancy Outcomes in HIV-Infected Women of Advanced Maternal Age 241
The non-conventional (folding) protease inhibitor blocks the human immunodeficiency virus type-1 replication without evidence of resistance during in vitro passage 235
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics 233
Interruption of highly active antiretroviral therapy in HIV clinical practice : results from the Italian Cohort of Antiretroviral-Naive Patients 232
Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy 232
Body habitus changes and metabolic alterations in protease inhibitor-naïve HIV-1-infected patients treated with two nucleoside reverse transcriptase 227
IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients 226
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine 226
Chronic coinfection with hepatitis B and hepatitis C viruses in an Italian population of HIV-infected patients 225
Increased risk of developing peripheral neuropathy in patients coinfected with HIV-1 and HTLV-2 222
Polymorphonuclear leukocyte function in burned patients : effect of isoprinosine 221
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure 219
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors 216
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people 211
HIV type 1 phenotype correlates with the stage of infection in vertically infected children 211
Key questions in antiretroviral therapy : Italian Consensus Workshop (2005) 208
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. 207
Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin 207
Polymorphonuclear leucocyte function during acute viral hepatitis 206
ADAMTS 13 genotype and vWF protease activity in an Italian family with TTP 204
Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein 203
Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting 203
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy 200
High prevalence of false-negative anti-HTLV type I/II enzyme-linked immunosorbent assay results in HIV type 1-positive patients 198
Clinical aspects of the AIDS dementia complex in relation to histopathological and immunohistochemical variables 195
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient 195
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment 194
Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS 194
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals 192
Predictive role of the three-month CD4 cell count in the long-term clinicaloutcome of the first HAART regimen 191
HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis 190
Standardisation of EGFR FISH in colorectal cancer: Results of an international interlaboratory reproducibility ring study 189
Mezzi di accertamento diagnostico in patologia infettiva 185
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy 183
KSHV reactivation in post-transplant Kaposi sarcoma 182
Patogenesi delle malattie infettive 180
Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals 179
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection 179
Overview on HIV-1-related drug resistance: from theory to clinical practice 179
Incidence of adipose tissue alterations in first-line antiretroviral therapy 175
Rapid onset of M184V mutation and phenotypic resistance to stavudine in zidovudine pre-treated HIV-1-infected individuals receiving the therapeutic regimens zidovudine plus lamivudine or stavudine plus lamivudine 174
Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues : the SMART study 173
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients 170
Acute type B hepatitis in parenteral drug-addicts (PDA): prognostic value of circulating HBsAg/IgM complexes 168
Survival differences for 547 AIDS cases in Milan. 167
Cortisol resistance in acquired immunodeficiency syndrome 164
Leukocyte function after antenatal betamethasone given to prevent respiratory distress 163
Impact of treatment and prophylaxis on presentation and survival of patients with AIDS in Milan 162
Comparison of metabolic abnormalities 48 weeks after switching from highly active antiretroviral therapy containing a non-nucleoside reverse transcriptase inhibitor to Trivizir versus continued highly active antiretroviral therapy. 161
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons 161
Valutazione dell’utilizzo clinico della polymerase chain reaction nella diagnosi di malattia tubercolare 160
First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-Infected Patients in the HAART Era (2006) 160
[Generalized and persistent lymphadenopathy in drug addicts: clinical and epidemiological aspects] 160
T-cell subsets and serum immunoglobulin levels in infants born to HIV-seropositive mothers : a longitudinal evaluation 159
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine 159
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy 159
Italian multicentre study of didanosine compassionate use in advanced HIV infection 157
EGFR FISH in colorectal cancer: what is the current reality? 157
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer 157
Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children 156
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals 155
Salivary stone lithotripsy in the HIV patient 154
Inosiplex in recurrent herpes simplex infections 154
Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS 153
Atypical mycobacterial disease findings at autopsy in a cohort of 350 AIDS patients in Milan, Italy 149
Albendazole in the treatment of cystic hydatid disease 148
Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results 147
Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy 146
Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial 146
Survival in a cohort of 1205 patients from Milan. 146
Totale 22.893
Categoria #
all - tutte 73.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021740 0 0 0 0 0 0 0 0 0 0 570 170
2021/20222.183 137 101 65 62 118 98 204 290 315 240 188 365
2022/20232.420 279 226 208 310 283 506 47 131 273 21 84 52
2023/20241.467 48 120 43 76 323 99 77 119 57 105 165 235
2024/20253.775 197 338 110 434 298 136 131 460 210 340 288 833
2025/20267.753 702 415 802 674 797 646 1.118 440 825 635 699 0
Totale 31.534